SMAD3 and renal fibrosis: A recent study has shown that knockdown of CDK9 and a CDK9 inhibitor (LDC000067) could remarkably ameliorate renal fibrosis by blocking the phosphorylation of the Smad3 linker (Thr179) (Qu et al., 2015).